LBBW Aktienanleihe OMV 28.03.2025/ DE000LB43K68 /
05/08/2024 11:15:10 | Chg.-0.330 | Bid12:31:03 | Ask12:31:03 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
99.510EUR | -0.33% | 99.460 Bid Size: 250,000 |
99.860 Ask Size: 250,000 |
OMV AG | 31.36 EUR | 28/03/2025 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
13/10/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center